BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22520980)

  • 21. Hedgehog inhibitors from Withania somnifera.
    Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hedgehog inhibitors: a patent review (2013 - present).
    Xin M
    Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Galperin I; Dempwolff L; Diederich WE; Lauth M
    J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
    O'Toole SA; Swarbrick A; Sutherland RL
    Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Hedgehog Antagonists for Cancer Therapy.
    Khatra H; Bose C; Sinha S
    Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hedgehog pathway as a therapeutic target for treatment of breast cancer.
    Barginear MF; Leung M; Budman DR
    Breast Cancer Res Treat; 2009 Jul; 116(2):239-46. PubMed ID: 19479372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors.
    Banerjee U; Ghosh M; Kyle Hadden M
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1330-4. PubMed ID: 22226657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
    Yun JI; Kim HR; Park H; Kim SK; Lee J
    Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hedgehog signaling pathway and cancer therapeutics: progress to date.
    Ruch JM; Kim EJ
    Drugs; 2013 May; 73(7):613-23. PubMed ID: 23605693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to target the Hedgehog signaling pathway for cancer therapy.
    Xin M; Ji X; De La Cruz LK; Thareja S; Wang B
    Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of anticancer agents targeting the Hedgehog signaling.
    Zhang X; Tian Y; Yang Y; Hao J
    Cell Mol Life Sci; 2017 Aug; 74(15):2773-2782. PubMed ID: 28314894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway.
    Alfonsi R; Botta B; Cacchi S; Di Marcotullio L; Fabrizi G; Faedda R; Goggiamani A; Iazzetti A; Mori M
    J Med Chem; 2017 Feb; 60(4):1469-1477. PubMed ID: 28122186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Hedgehog signaling pathway for cancer therapy.
    Li Y; Maitah MY; Ahmad A; Kong D; Bao B; Sarkar FH
    Expert Opin Ther Targets; 2012 Jan; 16(1):49-66. PubMed ID: 22243133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.
    Salaritabar A; Berindan-Neagoe I; Darvish B; Hadjiakhoondi F; Manayi A; Devi KP; Barreca D; Orhan IE; Süntar I; Farooqi AA; Gulei D; Nabavi SF; Sureda A; Daglia M; Dehpour AR; Nabavi SM; Shirooie S
    Pharmacol Res; 2019 Mar; 141():466-480. PubMed ID: 30639373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging from their burrow: Hedgehog pathway inhibitors for cancer.
    Gan GN; Jimeno A
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1153-66. PubMed ID: 27459882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.
    Malancona S; Altamura S; Filocamo G; Kinzel O; Hernando JI; Rowley M; Scarpelli R; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4422-8. PubMed ID: 21737272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of hedgehog signaling pathway inhibitors.
    Liu H; Gu D; Xie J
    Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Hedgehog--a cancer stem cell pathway.
    Merchant AA; Matsui W
    Clin Cancer Res; 2010 Jun; 16(12):3130-40. PubMed ID: 20530699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in the discovery of small molecule Hedgehog pathway antagonists.
    Tremblay MR; McGovern K; Read MA; Castro AC
    Curr Opin Chem Biol; 2010 Jun; 14(3):428-35. PubMed ID: 20399136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intricacies of hedgehog signaling pathways: a perspective in tumorigenesis.
    Kar S; Deb M; Sengupta D; Shilpi A; Bhutia SK; Patra SK
    Exp Cell Res; 2012 Oct; 318(16):1959-72. PubMed ID: 22659135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.